Document is current

Any future updates will be listed below

Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?

Crossref DOI link: https://doi.org/10.1007/s11102-016-0708-3

Published Online: 2016-02-01

Published Print: 2016-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark